MODELING THE COST-EFFECTIVENESS OF THE ALL ORAL, DIRECT-ACTING ANTIVIRAL REGIMEN DACLATASVIR PLUS SOFOSBUVIR IN PATIENTS CO-INFECTED WITH HEPATITIS C VIRUS (HCV) AND HIV

被引：3
作者：
McEwan, P. [1 ]
Ward, T. [1 ]
Webster, S. [1 ]
Kalsekar, A. [2 ]
Brenner, M. [3 ]
Yuan, Y. [2 ]
机构：
[1] Hlth Econ & Outcomes Res Ltd, Monmouth, Wales
[2] Bristol Myers Squibb Pharmaceut Ltd, Princeton, NJ USA
[3] Bristol Myers Squibb Pharmaceut Ltd, Uxbridge, Middx, England
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 07期
关键词：
D O I：
10.1016/j.jval.2015.09.2213
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PGI32
引用
收藏
页码：A628 / A628
页数：1
相关论文
共 50 条
[41]   SOFOSBUVIR-BASED DIRECT-ACTING ANTIVIRALS TREATMENT FOR ELDERLY CHRONIC HEPATITIS C PATIENTS: A COST-EFFECTIVENESS ANALYSIS [J].
Ciaccio, A. ;
Cortesi, P. A. ;
Bellelli, G. ;
Rota, Matteo ;
Rota, Monica ;
Okolicsanyi, S. ;
Mantovani, L. G. ;
Annoni, G. ;
Strazzabosco, M. .
JOURNAL OF HEPATOLOGY, 2015, 62 :S639-S639
[42]   COST-EFFECTIVENESS OF TREATMENT WITH PEGASYS/COPEGUS IN HIV/HCV CO-INFECTED PATIENTS IN PORTUGAL [J].
Macedo, A. ;
Monteiro, I ;
Nunes, S. ;
Farinha, S. ;
Pereira, C. .
VALUE IN HEALTH, 2008, 11 (06) :A436-A437
[43]   Cost Effectiveness of Early Treatment with Direct-Acting Antiviral Therapy in Adolescent Patients with Hepatitis C Virus Infection [J].
Nguyen, Joehl ;
Barritt, A. Sidney ;
Jhaveri, Ravi .
JOURNAL OF PEDIATRICS, 2019, 207 :90-96
[44]   Ocular comorbidities with direct-acting antiviral treatment for chronic hepatitis C virus (HCV) patients [J].
Abd Elaziz, Mohamed Samy ;
Nada, Ali Saad Eldeen ;
ElSayed, Saber Hamid ;
Nasr, Ghada Salah ;
Zaky, Adel Galal .
INTERNATIONAL OPHTHALMOLOGY, 2020, 40 (05) :1245-1251
[45]   Ocular comorbidities with direct-acting antiviral treatment for chronic hepatitis C virus (HCV) patients [J].
Mohamed Samy Abd Elaziz ;
Ali Saad Eldeen Nada ;
Saber Hamid ElSayed ;
Ghada Salah Nasr ;
Adel Galal Zaky .
International Ophthalmology, 2020, 40 :1245-1251
[46]   RAISING HOPE: IMPROVED OUTCOMES FOR HIV/HCV CO-INFECTED LIVER TRANSPLANT RECIPIENTS IN THE DIRECT-ACTING ANTIVIRAL ERA [J].
Wang, Jennifer ;
Cotter, Thomas ;
Rich, Nicole E. ;
Lieber, Sarah R. ;
Marrero, Jorge A. ;
Singal, Amit G. ;
Aronsohn, Andrew ;
Charlton, Michael ;
Fung, John .
GASTROENTEROLOGY, 2021, 160 (06) :S766-S766
[47]   COST-EFFECTIVENESS AND MODELING APPROACHES OF DIRECT-ACTING ANTIVIRAL AGENTS IN CHRONIC HEPATITIS C INFECTION: A SYSTEMATIC LITERATURE REVIEW [J].
Szilberhorn, L. ;
Agh, T. ;
Fasseeh, A. N. ;
Kalo, Z. .
VALUE IN HEALTH, 2017, 20 (09) :A411-A411
[48]   Direct-acting antiviral therapy in HIV/HCV co-infected patients can significantly reduce liver fibrosis: a prospective cohort study [J].
Easdon, S. ;
Edwards, S. ;
Nelson, M. .
HIV MEDICINE, 2017, 18 :37-37
[49]   Benefit of direct-acting antiviral therapy in hepatitis C virus (HCV) monoinfected and HIV-HCV coinfected patients with mixed cryoglobulinemia [J].
Diakite, M. ;
Hartig-Lavie, K. ;
Miailhes, P. ;
Pradat, P. ;
Uhres, A. -C. ;
Zoulim, F. ;
Sarda, M. -N. .
JOURNAL OF HEPATOLOGY, 2017, 66 (01) :S528-S529
[50]   Direct-acting antiviral drugs (DAAs) for the treatment of chronic HCV infection in HIV co-infected patients: a monocentric experience in real life [J].
Izzo, Ilaria ;
Casari, Salvatore ;
Vavassori, Andrea ;
Nasta, Paola ;
Odolini, Silvia ;
Castelnuovo, Filippo ;
Bergamasco, Alberto ;
El Hamad, Issa ;
Paraninfo, Giuseppe ;
Spinetti, Angiola ;
Zaltron, Serena ;
Urbinati, Lucia ;
Biasi, Luciano ;
Foca, Emanuele ;
Festa, Elena ;
Cristini, Graziella ;
Castelli, Francesco .
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2016, 19
12345